Kelly Brady, See Remarks at Seres Therapeutics, Inc. (MCRB), sold 64 shares at $4.55 ($291) on 2026-08-17, disclosed to the SEC on 2026-08-18.
Scheduled sale ($291) by See Remarks under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.